C
인바이오젠
101140KOSPI기계장비 및 관련 물품 도매업47.3 / 100
Reference Date: 2026-07-24
Financial Score23.0 / 40
News Sentiment11.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 20.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Inbios operates primarily in kiosk distribution and F&B business, with the kiosk market growing due to AI and voice recognition technology integration. Kiosk business accounts for 89.6% of total revenue, while F&B business targets the MZ generation with differentiated menus and services.
Number of Employees
28people
Average Salary
48.8M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 8.654.0Point
PBR
0.33Industry Average 0.585.5Point
Lower than industry avg (good)
ROE
-0.89Industry Average 2.780.0Point
Well below industry avg
Debt Ratio
0.31Industry Average 6.768.0Point
Half of industry avg (excellent)
Trend 2023~20255.5 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲1.1% (2-year basis)
Operating Profit Growth Rate
2.5 / 3
Avg ▲14.9% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 6.3% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 0Negative 1Average Sentiment Score 45
- Negative빗썸-키움증권 지분 협의…끝까지 갈지는 '미지수'
복잡한 지배구조와 규제 리스크로 인해 인바이오젠에 대한 빗썸과 키움증권의 지분 투자 성사 가능성은 낮아 보입니다.
Detailed Momentum
52-week position1.0Point
Near 52w low (2%, downtrend)
Current 5,170Won52-week high 13,84052-week low 4,985
1-month return0.0Point
1m -20.46% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-06-30
- Neutral임시주주총회결과2026-06-30